| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
HepG2 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
QGY-7703 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
1.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
5.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
10.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
| Niclosamide |
Influence on cell viability |
MTT Assay |
20.00 µM |
SMMC-7721 |
Homo sapiens |
|
|
|
